Melatonin M. Its role in regulation of circadian rhythm of inflammatory reaction in rheumatoid arthritis

1. <div><p>Адекберова З.С, Фолмеев Ю.В. О роли эстрогенан- дрогенового дисбаланса при ревматических заболеваниях. Тер. архив, 1990, 5, 17-22.</p><p>Harbus M.S., Jessop D.S. Is there a defect in cortisol production in rheumatoid arthritis? Rheumatology (Oxford), 1999, 38, 298-302.</p><p>Kanik K.S., Chrousos G.P., Schumacher H.R. et al. Adrenocortieotropin, glucocorticoid, and androgen secretion in patients with new onset synovitis/rheumatoid arthritis: relations with indices of inflammation. J. Clin. Endocrinol. Metab., 2000,85, 1461-1466.</p><p>Labrecque G., Bureau J.P., Reinberg A.E. Biological rhythms in the inflammatory response and in the effects of non-steroidal anti-inflammatory drugs. Pharmac. Ther., 1995, 66, 285-300.</p><p>Harkness J.A.L., Richter M.B., Panayi G.S. et al. Circadian variations in disease activity in rheumatoid arthritis. BMJ, 1982, 284. 551-554. '</p><p>Cutolo М., Villaggio B., Otsa K. et al. Aitered circadian rhythms in rheumatoid arthritis patients play a role in the disease's symptoms. Autoimmun. Rev. 2005, 8, 497-502.</p><p>Petrovsky N., McNair P., Harrison L.C. Diurnal rhythms of pro-inflammatory cytokines: regulation by plasma cortisol and therapeutic implications. Cytokine, 1998, 10(4), 307-312.</p><p>Arvidson N.G., Gudbjornsson B., Elfman L. et al. Circadian rhythm of serum interleukin-6 in rheumatoid arthritis. Ann. Rheum. Dis., 1994, 53(8), 521-524.</p><p>Crofford L.J, Kalogeras K.T, Mastorakos G. et al. Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis. J. Clin. Endocrinol. Metab., 1997,82,1279-1283.</p><p>MastorakosG.,CluvusosG.P., Weber J.S. Recombinant interleukin-6 activates the hypothalamic-pituitary- adrenal axis in humans. J. Clin. Endocrinol. Metab., 1993, 77, 1690-1694.</p><p>Naitoh Y., FukataJ., Tominaga T. et al. Interleukin-6 stimulates the secretion of adrenocorticotropic hormone in conscious, freely-moving rats. Biochem. Biophys. Res. Commun., 1988, 155, 1459-1463.</p><p>Tsigos C., Papanicolaou D.A., Defensor R. et al. Dose-effects of recombinant human interleukin-6 on pituitary hormone secretion and energy expenditure.Neuroendocrinology, 1997, 66, 54—62.</p><p>Papanicolaou D.A., Tsigos С., Torpy D.J. et al. Recombinant interleukin-6 effects on pituitary secretion in humans /Abstractj. J. Invest. Med., 1996, 44, A266.</p><p>Breuninger L.M., Dempsey W.L., Uhl J., Murasko D. M. Hydrocortisone regulation of interleukin-6 protein production by a purified population of human peripheral blood monocytes. Clin. Immunol. Immunopathol., 1993,69, 205-214.</p><p>Rock C.S., Coyle S.М., Keogh C.V. et al. Influence of hypercortisolemia on the acute-phase protein response to endotoxin in humans. Surgeiy, 1992, 112, 467-474.</p><p>Papanicolaou D.A., Petrides J.S., Tsigos C. et al. Exercise stimulates interleukin-6 secretion: inhibition by glucocorticoids and correlation with catecholamines. Am. J. Physiol. 1996, 271, 601-605.</p><p>Papanicolaou D.A., Tsigos C., OldfieldE.H., Chrousos G. P. Acute glucocorticoid deficiency is associated with plasma elevations of interleukin-6: does the latter participate in the symptomatology of the steroid withdrawal syndrome and adrenal insufficiency? J. din. Endocrinol. Metab., 1996, 81, 2303—2306.</p><p>Van den Brink H.R, Blankenstein M.A, Koppeschaar H. P, Bijlsma J. W. Influence of disease activity on steroid hormone levels in peripheral blood of patients with rheumatoid arthritis. Clin. Exp. Rheumatol. 1993, II, 649-652.</p><p>Hall J. Morand E.F. Medbak S. el al. Abnormal hypothalamic-pituitary-adrenal axis function in rheumatoid arthritis: effects of nonsteroidal antiinflamma- torv drugs and water immersion. Arthr. Rheum., 1994. 37, 1132-1137.</p><p>Gudbjornsson B., Skogscid B., Oberg K. et al. Intact adrenocorticotropic hormone secretion but impaired cortisol response in patients with active rheumatoid arthritis: effect of glucocorticoids. J. Rheumatol., 1996, 23, 596-602.</p><p>Tempi E., Koellcr M. Riedl М., etal. Anterior pituitary function in patients with newly diagnosed rheumatoid arlhritis. Br. J. Rheumatol., 1996,35, 350-356.</p><p>Chrousos G.P. Torpy D.J., Gold P.W. Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: clinical implications. Ann. Intern. Med., 1998, 129, 229-240.</p><p>Cutolo М., Foppiani L. PreteC. et al. Hypothalamic- pituitary-adrenocortical axis function in premenopausal women with rheumatoid arthritis not treated with glucocorticoids. J. Rheumatol., 1999, 26, 282-288.</p><p>Gutierrez. M.A, Garcia M.E, Rodriguez J.A. et al. Hypothalamic-pituitiiry-adrenal axis function in patients with active rheumatoid arthritis: a controlled study using insulin hypoglycemia stress test and prola- clin stimulation. J. Rheumatol., 1999, 26, 277-281.</p><p>Demir H., Kelestimur F., Tunc M. et al. Hypo- thalamo-pituitary-adrenal axis and growth hormone axis in patients with rheumatoid arthritis. Scand. J. Rheumatol., 1994, 28, 41-46.</p><p>Straub R.H, Paimela L., Peltomaa R. et al. Inadequately low serum levels of steroid hormones in relation to interleukin-6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis. Arthr. Rheum., 2002, 46(3), 654-662.</p><p>Chikanza I.C., Petrou P., Kingsley G. et al. Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthr. Rheum., 1992, 35(11), 1281-1288.</p><p>Straub R.H., Cutolo M. Involvment of the hypothalamic-pituitary-adrenal/gonadal axis and periphe- rial nervous system in rheumatoid arthritis: viewpoint based on a systemic pathogenetic role. Arthr. Rheum., 2001, 44, 493-507.</p><p>Dekkers J.K., Greenen R., Godaert G.L.R. et at. Diurnal rhythm of salivary cortisol levels in patients with recent-onset rheumatoid arthritis. Arthr. Rheum., 2000, 43, 465-467.</p><p>Kirschbaum C., Hellhammer D.H. Salivary cortisol in psychological research: an overview. Neuropsychobiology, 1989, 22, 150-169.</p><p>Schmidt — Reinvald A., Pmessner J.C., Hellhammer D. H. et at. The cortisol response to awakening in relation to different challenge tests and a 12-hour corlisol rhythm. LifeSci., 1999, 64, 1653-1660.</p><p>Мелатонин в норме и патологии. Под ред. Комарова Ф.И., Рапопорта С. П., Малиновской Н.К., Анисимова В.Н. М, 2004, 7-85.</p><p>Левин Я. И. Мелатонин (Мелаксен) в терапии инсомнии. РМЖ, 2005, 13. 7, 498-501.</p><p>Кветная Т.В, Князькин И.В. Мелатонин, роль и значение в возрастной патологии. Санкт- Петербург, 2004, 5-23.</p><p>Ковальзон В. М. Мелатонин, эпифиз и сон млекопитающих. Нейрохимия, 2003, 20, 2, 93-100.</p><p>Maestroni GJ. The immuneneuroendocrine role of melatonin. J. Pineal. Res., 1993, 14, 1—10.</p><p>Maestroni G.J. T-helper 2 lymphocytes as a peripheral target of melatonin. J. Pineal. Res., 1995,18, 84—89.</p><p>Giordano М., Palermo M.S. Melatonin-induced enhancement of antibody-dependent cellular cytotoxicity. J. Pineal. Res., 1991, 10, 117-121.</p><p>Liu F., Ng T.B., Fung M.C. Pineal indoles stimulate the gene expression of immunomodulating cytokines. J. Neural. Transm., 2001, 108, 397-405.</p><p>Garcia-Mauriho S., Gonzalez-Haba M.G., CalvoJ.R. et al. Melatonin enhances IL-2, IL-6, and IFNy production by human circulating CD4+ cells: a possible nuclear receptor-mediated mechanism involving T helper type 1 lymphocytes and monocytes. J. Immunol., 1997, 159, 574-581.</p><p>Carrillo-Vico A., Garcia-Mauriho S., Calvo J.R., Guerrero J.M. Melatonin counteracts the inhibitory effect of PGE2 on IL-2 production in human lymphocytes via its mtl membrane receptor. FASEB J., 2003, 17, 755-757.</p><p>Baijavel M.J., Mamdouh Z, Raghbate N., Bakouche O. Differential expression of the melatonin receptor in human monocytes. J. Immunol., 1998, 160, 1191-1197.</p><p>Morrey K.M., Me Lachlan J.A., Serkin C.D., Bakouche 0. Activation of human monocytes by the pineal hormone melatonin. J. Immunol., 1994, 153, 2671-2680.</p><p>Gonzalez-Haba M.G., Garcia-Maurino S., CalvoJ.R. et al. High-affinity binding of melatonin by human circulating T lymphocytes (CD4+). FASEB J., 1995, 9(13). 1331-1335.</p><p>Lopez-Gonzalez M.A., Calvo J.R., Segura J.J., Guerrero J.M. Characterization of melatonin binding sites in human peripheral blood neutrophils. Biotechnol. Then, 1993, 4(3-4), 253-262.</p><p>Conti A., Conconi S., Hertens E. et al. Evidence for melatonin synthesis in mouse and human bone marrow celb. J. Pineal. Res., 2000, 28, 193—202.</p><p>Tan D.X., Manchester L.C., Reiter R.J. et al. Identification of highly elevated levels of melatonin in bone marrow: its origin and significance. Biochim. Biophys. Acta., 1999, 1472, 206-214.</p><p>Carrillo-Vico A., Calvo J.R., Abreu P. et al. Evidence of melatonin synthesis by human lymphocytes and its physiological significance: possible role as intracrine, autocrine, and/or paracrine substance. FASEB J., 2004. 18, 537-539.</p><p>Guerrero J.M., Reiter R.J. Melatonin-immune system relationships. Curr. Top. Med. Chem., 2002, 2, 167-179.</p><p>Topal Т., Oter S., Korkmaz A. et al. Exogenously administered and endogenously produced melatonin reduce hyperbaric oxygen-induced oxidative stress in rat lung. LifeSci., 2004, 75, 461—467.</p><p>Pahlavani M.A., Harris M.D. In vitro effects of melatonin on mitogen-induced lymphocyte proliferation and cytokine expression in young and old rats. Immunopharmacol. Immunotoxicol., 1997, 19, 327-337.</p><p>Di StefanoA. Paulesu L. Inhibitory effect of melatonin on production of IFNy or TNFa in peripheral blood mononuclear cells of some blood donors. J. Pineal. Res., 1994, 17, 164-169.</p><p>Pioli C., Caroleo M.C., Nistico G., Doria G. Melatonin increases antigen presentation and amplifies specific and nonspecific signals for T-cell proliferation. Int. J. Immunopharmacol., 1993, 15, 463—468.</p><p>Demas G.E., Nelson R.J. Exogenous melatonin enhances cell-mediated, but not humoral, immune function in adult male deer mice (Peromyscus manicu- latus). J. Biol. Rhythms., 1998, 13, 245-252.</p><p>Martins Jr.E., Fernandes L.C., Bartol I. et al. The effect of melatonin chronic treatment upon macrophage and lymphocyte metabolism and function in Wallcer-256 tumour-bearing rats. J. Neuroimmunol., 1998, 82, 81-89.</p><p>Giordano М., Vermeulen М., Palermo M.S. Seasonal variations in antibody-dependent cellular cytotoxicity regulation by melatonin. FASEB J., 1993, 7, 1052-1054.</p><p>Carrillo-Vico A., Garcia-Perganeda A., Naji L. etal. Expression of membrane and nuclear melatonin receptor mRNA and protein in the mouse immune system. Cell. Mol. Life Sci., 2003, 60, 2272 - 2278.</p><p>Drazen, D.L., Nelson R.J. Melatonin receptor subtype MT2 (Mel lb) and not mtl (Mel la) is associated with melatonin-induced enhancement of cell-mediated and humoral immunity. Neuroendocrinology, 2001, 74, 178- 184.</p><p>Rafii-EI-ldrissi М., Calvo J.R., Harmouch A. et al. Specific binding of melatonin by purified cell nuclei from spleen and thymus of the rat. J. Neuroimmunol., 1998, 86, 190- 197.</p><p>Morrey K.M., McLachlan J.A., Serkin C.D., Bakouche O. Activation of human monocytes by the pineal hormone melatonin. J. Immunol., 1994, 153, 2671-2680.</p><p>Garcia-Maurino S., Gonzalez-Haba M.G., Calvo J.R. et al. Melatonin enhances IL-2,1L-6 and JFN-y production by human circulating CD4+ cells. J. Immunol., 1997, 159, 574-581.</p><p>Cutolo М., Seriolo B., Craviotto C. et al. Circadian rhythms in RA. Ann. Rheum. Dis., 2003, 62, 593-596.</p><p>Maestroni G.J.M, Conti A., Pierpaoli W. Role of the pineal gland in immunity. Circadian synthesis and release of melatonin modulates the antibody response and antagonize the immunosuppressive effect of corticosterone. J. Neuroimmunol., 1986, 13, 19-30.</p><p>Sainz R.M., Mayo J.C., Reiter R.J. et al. Melatonin regulates glucocorticoid receptor: an answer to its antiapoptotic action in thymus. FASEB J., 1999, 13, 1547-1556.</p><p>SulliA., MaestroniG.J.М., Villaggio В. etal. Melatonin serum levels in rheumatoid arthritis. Ann. NY Acad. Sci., 2002, 966, 276-83.</p><p>Schulze-Koops H., Lipsky P.E., Kavanaugh A.F., Davis L.S. Elevated Thl- or ThO-like cytokine mRNA in peripheral circulation of patients with rheumatoid arthritis. J. Immunol., 1995, 155, 5029—5037.</p><p>Maestroni G.J.М., SulliA., Pizzorni C. etal. Melatonin in rheumatoid arthitis: synovial macrophages show melatonin receptors. Ann. NY Acad. Sci., 2002, 966, 271-275.</p><p>Maestroni G.J. M., Sulli A., Pizzorni C. et al. Melatonin in rheumatoid arthritis: a disease promoting and modulating hormone? Clin. Exp. Rheumatol., 2002, 20, 872-873.</p><p>Cantorna М. T. Vitamin D and autoimmunity: is vitamin D status an environmentalfactor affecting autoimmune disease prevalence? Proc. Soc. Exp. Biol. Med., 2000, 223, 230-233.</p><p>Rozin A., Balbir-Gurman A., Chapira D. Seasonal distribution of relapse onset in rheumatoid arthritis and spondyloarthropathy: the possible effect of solar factor. Clin. Exp. Rheumatol., 2003, 21, 161-169.</p><p>Cutolo M. Solar light effects on onset/releases and circannual/circadian symptomatology in rheumatoid arthritis. Clin. Exp. Rheumatol., 2003, 21, 148-150.</p><p>Cutolo М., Maestroni G.J.M., Otsa K. et al. Circadian melatonin and cortisol levels in rheumatoid arthritis patients in winter time: a north and south Europe comparison. Ann. Rheum. Dis., 2005, 64, 212-216.</p><p>Abdel-Nasser A.M., Rasker J.J., Valkenburg H.A. Epidemiological and clinical aspects relating to the variability of rheumatoid arthritis. Semin. Arthr. Rheum., 1997, 27, 123-140.</p><p>Drewes A.M., Svendsen L., Taagholt S.J. etal. Sleep in rheumatoid arthritis: a comparison with healthy subjects and studies of steep/wake interactions. Br. J. Rheumatol., 1998, 37, 71-81.</p><p>Kapsimalis F, Richardson G., Opp M.R., Kryger M Cytokines and normal sleep. Curr. Op in. Pulm. Med., 2005, 11(6), 481-484.</p><p>Reiter R.J., Melchiorri D., Sewerynek E. et al. A review of the evidence supporting melatonin’s role as an antioxidant. J. Pineal. Res., 1995, 18(1), 1-11.</p><p>Каратеев A.E., Каратеев Д.Е., Лучихина Е.Л., Насонова B.A. Первый опыт применения мелатонина для коррекции нарушений сна у больных с ревматоидным артритом. Научно-практ. ревматол., 2004, 4, 73-76.</p><p>Forrest С. М., Mackay G.M., Stoy N. et a I. Inflammatory status and kynurenine metabolism in rheumatoid arthritis treated with melatonin. Br. J. Clin. Pharmacol., 2007, 15, [Epub ahead of print].</p></div><br />